Middle-Ear 发表于 2025-3-27 00:28:40

http://reply.papertrans.cn/83/8291/829098/829098_31.png

Confound 发表于 2025-3-27 01:08:45

http://reply.papertrans.cn/83/8291/829098/829098_32.png

发出眩目光芒 发表于 2025-3-27 06:37:11

http://reply.papertrans.cn/83/8291/829098/829098_33.png

Tidious 发表于 2025-3-27 13:22:36

Springer Theseshttp://image.papertrans.cn/r/image/829098.jpg

Offbeat 发表于 2025-3-27 16:46:51

http://reply.papertrans.cn/83/8291/829098/829098_35.png

ASSET 发表于 2025-3-27 18:41:28

http://reply.papertrans.cn/83/8291/829098/829098_36.png

Custodian 发表于 2025-3-27 23:36:19

http://reply.papertrans.cn/83/8291/829098/829098_37.png

faultfinder 发表于 2025-3-28 03:47:32

Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents,osuppressive [.,.,.,.,.]. Consequently, evaluation of new chemotherapeutic agents involved screening of drug candidates upon xenografted tumors in immunodeficient mice which neglects any possible immune contribution.
页: 1 2 3 [4]
查看完整版本: Titlebook: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches; Daniel Yuan Qiang‘Wong Book 2018 Spri